Invivyd Inc宣布,公司的Declaration和Liberty临床试验计划在2025年底前后开始进行。该公司预计相关试验的主要临床数据将在2026年中期对外公布。
这两项临床试验的启动标志着Invivyd Inc在其研发管线推进方面的重要里程碑,市场将密切关注试验进展及后续数据发布情况。
Invivyd Inc宣布,公司的Declaration和Liberty临床试验计划在2025年底前后开始进行。该公司预计相关试验的主要临床数据将在2026年中期对外公布。
这两项临床试验的启动标志着Invivyd Inc在其研发管线推进方面的重要里程碑,市场将密切关注试验进展及后续数据发布情况。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.